FR2551M - Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies. - Google Patents

Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies.

Info

Publication number
FR2551M
FR2551M FR928068A FR928068A FR2551M FR 2551 M FR2551 M FR 2551M FR 928068 A FR928068 A FR 928068A FR 928068 A FR928068 A FR 928068A FR 2551 M FR2551 M FR 2551M
Authority
FR
France
Prior art keywords
oxazolinone
asthenia
phenyl
amino
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR928068A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAUSSE LAB
Original Assignee
DAUSSE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAUSSE LAB filed Critical DAUSSE LAB
Priority to FR928068A priority Critical patent/FR2551M/fr
Application granted granted Critical
Publication of FR2551M publication Critical patent/FR2551M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR928068A 1963-03-15 1963-03-15 Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies. Expired FR2551M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR928068A FR2551M (fr) 1963-03-15 1963-03-15 Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR928068A FR2551M (fr) 1963-03-15 1963-03-15 Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies.

Publications (1)

Publication Number Publication Date
FR2551M true FR2551M (fr) 1964-05-25

Family

ID=8799291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR928068A Expired FR2551M (fr) 1963-03-15 1963-03-15 Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies.

Country Status (1)

Country Link
FR (1) FR2551M (fr)

Similar Documents

Publication Publication Date Title
DK106814C (da) Polermiddel egnet til anvendelse i tandplejemidler.
NL144526B (nl) Rasp.
NL152690B (nl) Informatieverwerkende inrichting.
NL156055B (nl) Bloedbehandelingsapparaat.
FR1397535A (fr) Transistor par alliage diffusé
OA00339A (fr) Composition pour le traitement des cheveux.
FR3111M (fr) Médicament a base de dérivé de cystéine.
FR2526M (fr) Médicament inhibiteur de la pyrocatechol-0-méthyltransferase.
OA00595A (fr) Dispositif d'activation.
FR2944M (fr) Médicament pour le traitement de la toux a base de 2-amino-6-méthylheptane.
FR2551M (fr) Médicament a base de (+) phényl-5 amino-2 oxazolinone-4 destiné en particulier au traitement des asthénies.
OA01035A (fr) Nouvelles coumarines substituées et leurs procédés de préparation.
FR3414M (fr) (thiényl-2')-1 oxo-1 amino-2 propanes et compositions pharmaceutiques.
FR2108854A1 (fr) Appareil d'extraction des pieces d'usinage
CH555656A (fr) Dispositif pour le traitement des cheveux.
NL144745B (nl) Kaartenuitwerpinrichting.
CH400407A (fr) Appareil d'usinage par électro-érosion
DK106635C (da) Tandplejemiddel.
DK103735C (da) Tandplejemiddel.
FR2690M (fr) Méthoxy-3α méthyl-17α 5&alpha-androstanol-17β.
FR1358659A (fr) Dispositif pour le traitement des cheveux
FR26F (fr) Médicament a base de dérivé d'amino oxazolinone, destiné, en particulier, au traitement des asthénies.
FR1243M (fr) Médicament a base de dérivé d'amino oxazolinone destiné, en particulier, au traitement des asthénies.
FR1385263A (fr) Perfectionnements au traitement des surfaces métalliques
FR1390897A (fr) Appareil de nettoyage, en particulier pour chaussures